Heterogeneity of cancer stem cell‐related marker expression is associated with three‐dimensional structures in malignant pleural effusion produced by lung adenocarcinoma

Triple-negative expression (ALDH1A1-/CD133-/mutant p53-) cases in lung adenocarcinoma had a good prognosis

(2022) Naoki Yamashita et al.   Scientific Reports

Computer-assisted three-dimensional quantitation of programmed death-ligand 1 in non-small cell lung cancer using tissue clearing technology

(2022) Yen-Yu Lin et al.   Journal of Translational Medicine

Claudin1 decrease induced by 1,25-dihydroxy-vitamin D3 potentiates gefitinib resistance therapy through inhibiting AKT activation-mediated cancer stem-like properties in NSCLC cells

(2022) Zhirong Jia et al.   Cell Death Discovery

Lung Cancer Stem Cell Markers as Therapeutic Targets: An Update on Signaling Pathways and Therapies

(2022) Yue Zheng et al.   Frontiers in Oncology

P21-activated kinase 2-mediated β-catenin signaling promotes cancer stemness and osimertinib resistance in EGFR-mutant non-small-cell lung cancer

(2022) Yanmei Yi et al.   ONCOGENE

NCAPG2 Maintains Cancer Stemness and Promotes Erlotinib Resistance in Lung Adenocarcinoma

(2022) Shiyao Jiang et al.   Cancers

ALDH1 and SALL4 Expression in Cell Block Samples from Patients with Lung Adenocarcinoma and Malignant Pleural Effusion

(2021) Tomohiro Kanayama et al.   Diagnostics

“Single‐cell pattern” of adenocarcinoma cells in effusion cytology: Morphologic challenges of lung cancer

(2020) Prerna Guleria et al.   DIAGNOSTIC CYTOPATHOLOGY

Overexpression of CD 133 and BCL‐2 in non‐small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement‐positive adenocarcinoma

(2019) Kiyoko Koyama et al.   PATHOLOGY INTERNATIONAL

Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis

(2019) Guichuan Huang et al.   OncoTargets and Therapy

Isolation and Identification of Cancer Stem-Like Cells in Adenocarcinoma and Squamous Cell Carcinoma of the Lung: A Pilot Study

(2019) Valentina Masciale et al.   Frontiers in Oncology

Epithelial-to-mesenchymal transition in the context of epidermal growth factor receptor inhibition in non-small-cell lung cancer

(2018) Giuseppe Bronte et al.   BIOLOGICAL REVIEWS

Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial–mesenchymal transition is critical in conquering ALK-positive lung cancer

(2018) Shinji Nakamichi et al.   Oncotarget

Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells

(2018) Ugo Testa et al.   Cancers

NANOG as an adverse predictive marker in advanced non–small cell lung cancer treated with platinum-based chemotherapy

(2017) Boksoon Chang et al.   OncoTargets and Therapy

Targeting Lung Cancer Stem Cells: Research and Clinical Impacts

(2017) Norashikin Zakaria et al.   Frontiers in Oncology

Impact of Cell Arrangement of Pleural Effusion in Survival of Patients with Breast Cancer

(2014) Natália Dressler Camillo et al.   ACTA CYTOLOGICA

Is CD133 Expression a Prognostic Biomarker of Non-Small-Cell Lung Cancer? A Systematic Review and Meta-Analysis

(2014) Hong Wu et al.   PLoS One

TrkB is responsible for EMT transition in malignant pleural effusions derived cultures from adenocarcinoma of the lung

(2013) Alberto Ricci* et al.   CELL CYCLE

Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade

(2013) Su-Feng Chen et al.   PLoS One

The CD44high Tumorigenic Subsets in Lung Cancer Biospecimens Are Enriched for Low miR-34a Expression

(2013) Saroj K. Basak et al.   PLoS One

Stearoyl-CoA desaturase-1 is a key factor for lung cancer-initiating cells

(2013) A Noto et al.   Cell Death & Disease

EMT markers in lung adenocarcinoma pleural effusion spheroid cells

(2012) Enrico Giarnieri et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Spheres Derived from Lung Adenocarcinoma Pleural Effusions: Molecular Characterization and Tumor Engraftment

(2011) Rita Mancini et al.   PLoS One

Lung Cancer Stem Cell: New Insights on Experimental Models and Preclinical Data

(2010) Caroline Rivera et al.   Journal of Oncology

Microtome-Free 3-Dimensional Confocal Imaging Method for Visualization of Mouse Intestine With Subcellular-Level Resolution

(2009) Ya–Yuan Fu et al.   GASTROENTEROLOGY

CD133 is indicative for a resistance phenotype but does not represent a prognostic marker for survival of non-small cell lung cancer patients

(2009) Alexei V. Salnikov et al.   INTERNATIONAL JOURNAL OF CANCER

Highly tumorigenic lung cancer CD133+ cells display stem-like features and are spared by cisplatin treatment

(2009) G. Bertolini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Drug-Selected Human Lung Cancer Stem Cells: Cytokine Network, Tumorigenic and Metastatic Properties

(2008) Vera Levina et al.   PLoS One